Investigational Site Number : 246002

Turku 20520

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Colorectal Cancer Metastatic, Hematological Malignancy

Studies at this site

• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen — Completed